The 8th International Symposium on Focused Ultrasound – a hybrid virtual and in-person four-day event held in Bethesda, MD –, includes an interactive virtual press briefing featuring the most recent clinical and preclinical advances and emerging applications of focused ultrasound.
Thomas O. Ryder, an investor, entrepreneur, and retired corporate executive, was elected to the Focused Ultrasound Foundation's Board of Directors at their March 1 meeting.
The early-stage, pilot trial aims to establish the safety of destroying a small target in the brain to treat chronic neuropathic pain.
A briefing featuring key data presented at the 6th International Symposium on Focused Ultrasound. Researchers and clinicians will highlight breakthrough advances in the use of focused ultrasound in cancer immunotherapy and for opening the blood-brain barrier (BBB).
Revolutionary Noninvasive Therapy Shows Promise for Immunotherapy and Opening Blood-Brain Barrier to Enable Treatment of Neurological Disease and Cancer
The results of the first ever clinical trial of focused ultrasound to open the blood-brain barrier (BBB) in patients with Alzheimer’s disease were published today in Nature Communications and also presented at the Alzheimer’s Association International Conference (AAIC) in Chicago, Illinois. The pilot trial demonstrated the feasibility and preliminary safety of focally, reversibly and repetitively opening the BBB.
Former CEO of Norfolk Southern and Amtrak, Charles W.
On Tuesday, June 5, Virginia Governor Ralph Northam visited the Focused Ultrasound Foundation and met with the Foundation’s staff as well as with members of the Foundation’s Board and Council, and donors. Virginia House of Delegates Leader David Toscano, representatives from the University of Virginia, and members of the local media were also in attendance.
Virginia Governor Ralph Northam will visit the Focused Ultrasound Foundation to discuss the impact of the State’s investment in pioneering this revolutionary technology. Invited guests will include the media, Foundation Board members, physicians and health industry leaders, and Foundation friends and supporters.
In a North American first, researchers at Sunnybrook Health Sciences Centre in Toronto have launched a pilot clinical trial to determine the safety, feasibility, and preliminary efficacy of using focused ultrasound to help patients with treatment-resistant major depression.
The first patient in a multicenter pivotal trial using focused ultrasound to address the major motor symptoms of Parkinson’s disease has been treated at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center in New York.
The Medical Imaging & Technology Alliance (MITA) announced that it has formed a partnership with the Focused Ultrasound Foundation to raise awareness of focused ultrasound technology among policymakers, payers, and medical specialty societies.
In November 2017, the Focused Ultrasound Foundation launched a new veterinary program to develop focused ultrasound therapies for the treatment of companion animals. The Foundation is currently supporting trials to investigate treating cancer and promote wound healing in pets – and more studies are in the pipeline.
Gary Shapiro, President and CEO of the Consumer Technology Association (CTA)™, which annually produces CES®, the largest technology and innovation show in the world, will deliver a keynote address at the 6th International Symposium on Focused Ultrasound on Tuesday, October 23, 2018, in Reston, Virginia.
The Focused Ultrasound Foundation will join life-changing technology innovators from around the world at CES 2018, taking place January 9–12 in Las Vegas. Known as the “Global Stage for Innovation,” CES will feature more than 3,900 exhibitors this year and host more than 170,000 attendees.
The Focused Ultrasound Foundation has launched a veterinary program to study focused ultrasound therapies for the treatment of animals. The initiative enables veterinary researchers to test state-of-the-art therapies in their patients, while collecting data necessary to accelerate the adoption of the technology for human applications.
The Focused Ultrasound Foundation has received a pledge of $10 million in unrestricted funds from an anonymous donor to be matched 1:1 by 2022. This pledge comes at a pivotal time for the Foundation and the focused ultrasound field.
For the first time, non-invasive focused ultrasound therapy is being used to ablate (or destroy) a portion of the primary tumor or metastatic tumors in conjunction with the cancer immunotherapy drug Keytruda.
The Focused Ultrasound Foundation announced that Richard Price, PhD, professor of biomedical engineering, radiology and radiation oncology at the University of Virginia, has been selected as the inaugural recipient of the $75,000 Andrew J. Lockhart Memorial Prize. Andrew’s parents, Terry and Eugene Lockhart, presented the prize to Dr. Price on October 2.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right